2801 - 2825 of 8808 Results
Title
Year
-
OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4587763Citation Count: 50
-
OPENTitle: Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive InclusionsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 42Issue #: 3Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-140162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4167919Citation Count: 23
-
OPENTitle: TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 1Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1110-0Best OA location URL: http://doi.org/10.1007/s00401-013-1110-0Citation Count: 90
-
OPENTitle: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1634End Page: 1651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031634Best OA location URL: http://hdl.handle.net/2286/R.I.43313Citation Count: 37
-
OPENTitle: Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 91Issue #: 10Start Page: 1292End Page: 1302Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23253Best OA location URL: http://doi.org/10.1002/jnr.23253Citation Count: 58
-
OPENTitle: Parkin mediates the degradation‐independent ubiquitination of Hsp70Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1806End Page: 1819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4432938Citation Count: 99
-
RESTRICTEDTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Citation Count: 1
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 60Issue #:Start Page: 129End Page: 140Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.08.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5653456Citation Count: 26
-
OPENTitle: Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesJournal Name: Biotechnology ProgressPublisher: WileyVol: 29Issue #: 2Start Page: 463End Page: 471Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/btpr.1698Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3618510Citation Count: 24
-
OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46
-
OPENTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://n.neurology.org/content/neurology/76/22/1866.full.pdfCitation Count: 68
-
OPENTitle: Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug DiscoveryJournal Name: The AAPS JournalPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 167End Page: 177Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1208/s12248-009-9090-7Best OA location URL: http://doi.org/10.1208/s12248-009-9090-7Citation Count: 160
-
OPENTitle: Cognitive performance of GBA mutation carriers with early-onset PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 18Start Page: 1434End Page: 1440Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318253d54bBest OA location URL: https://n.neurology.org/content/neurology/78/18/1434.full.pdfCitation Count: 258
-
OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Citation Count: 123
-
RESTRICTEDTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 38
-
OPENTitle: Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvationJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 441Issue #: 4Start Page: 862End Page: 866Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbrc.2013.10.159Best OA location URL: https://doi.org/10.1016/j.bbrc.2013.10.159Citation Count: 82
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: Postmortem interval effect on RNA and gene expression in human brain tissueJournal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 311End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10561-010-9210-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3343031Citation Count: 146
-
OPENTitle: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 4Start Page: 716End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061Best OA location URL: http://www.cell.com/article/S0896627314008964/pdfCitation Count: 111
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015OPENTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148083964/Eltoprazine_counteracts_L_DOPA_induced_SVENNINGSSON_Publishedonline5February2015_GOLD_VoR_CC_BY_NC_.pdfCitation Count: 152
-
OPENTitle: Molecular markers of early Parkinson's disease based on gene expression in bloodJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 104Issue #: 3Start Page: 955End Page: 960Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0610204104Best OA location URL: http://doi.org/10.1073/pnas.0610204104Citation Count: 502
-
OPENTitle: CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson DiseasesJournal Name: American Journal of Clinical PathologyPublisher: Oxford University Press (OUP)Vol: 129Issue #: 4Start Page: 526End Page: 529Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1309/w01y0b808emeh12lBest OA location URL: https://academic.oup.com/ajcp/article-pdf/129/4/526/24985935/ajcpath129-0526.pdfCitation Count: 263
-
OPENTitle: Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagyJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 10Start Page: 2245End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds040Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/10/2245/17254728/dds040.pdfCitation Count: 268